General Chair (In no particular order)
Nagy Habib
Professor, Imperial College London, UK.
Research field: Clinical Sciences, Oncology and Carcinogenesis, Public Health and Health Services, Paediatrics and Reproductive Medicine, Medical Biotechnology, Immunology.
Professor Nagy Habib is an academic surgeon and in July 2003 was awarded the position of professor of hepatobiliary surgery in the department of surgery and cancer, Faculty of Medicine, Imperial College London. He is director of the hepatopancreatobiliary (HPB) unit at Hammersmith Hospital, and in June 2007 was appointed a Pro Rector of Imperial College London and member of the College Management Board. Professor Nagy Habib pioneered the first clinical trial in the use of adenovirus for the treatment of liver cancer, as well as the use of plasmid gene therapy for hydrodynamic gene delivery. He is the first person in the West to publish a clinical trial on the use of autologous adult bone marrow-derived stem cells and RNA activation for the treatment of patients with liver insufficiency and liver cancer. He was selected as one of the top 10 surgeons in the UK by the Saturday Times Magazine and he was honoured to be elected to join the French Academy of Surgeons and the European Surgical Association. He held a gold award from the Advisory Committee for Clinical Excellencem, and the Winner of a Takreem Laureate award in 2012. He invented the Habib 4x liver resection device (acquired by AngioDynamics Inc 2015), and the Habib EndoHPB (won an Edison Gold award for Medical Innovation in 2020). He is the Founder of EMcision Ltd (medical device innovation), MiNA therapeutics (RNA therapeutics), Apterna (aptamer development), and Dawn Therapeutics (gene therapy). And he also elected Member of the French Académie Nationale de Chirurgie (2015). He has published more than 340 articles in scientific journals.
Wei Chen
Professor, XJTLU Entrepreneur College (Taicang), China.
Research field: Smart Chips, Sensing Technology, New Semiconductor Materials, Wearable Technology, Detection and Prevention of Diabetes and Early Cancer.
Dr. Wei Chen is a Fellow of the National Academy of Inventors in the United States and the Dean of the School of CHIPS at Xi'an Jiaotong-Liverpool University. He obtained his bachelor's degree from the School of Earth Sciences at Jilin University, his master's degree from the School of Geophysics at Central South University, and his Ph.D. from the School of Chemistry and molecular Engineering at Peking University. He previously served as the Deputy Director of the Semiconductor Materials Development Laboratory at the Chinese Academy of Sciences and received the CAS Young Scientist Award. Professor Wei Chen has long been engaged in cutting-edge nanotechnology research, and has published over 355 papers in internationally renowned academic journals such as Advanced Materials, PNAS, Nano Letters, and Signal Transduction and Targeted Therapy. His papers have been cited 22372 times so far, with an h-index of 76, and he holds 22 US patents. He was selected for the "Annual Scientific Impact" and "Lifetime Scientific Impact" lists in the "2024 Global Top 2% Scientists" ranking. Professor Chen has received the CAS Young Scientist Award, is a Fellow of the Royal Society of Chemistry, and has been honored with the Pencis Award for Excellence in Oncology and Cancer Research. In 2022, he was elected as a Fellow of the National Academy of Inventors, and in 2023, he became a Fellow of the Distinguished Scholars College at the University of Texas at Arlington, the highest honor the university bestows on faculty members. Through the efforts of Professor Chen and his team, the School of CHIPS has signed agreements with over a 30 companies and research institutes in the semiconductor field, jointly engaging in close cooperation in talent development, technological research and development, and other areas.
Pier Paolo Piccaluga
Associate Professor, University of Bologna, Italy.
Research field: Genomics of Hematological Malignancies, Metabolomics of Hematological Malignancies, Molecular Diagnostics, Digital pathology, Precision Medicine, Biobanking.
Pier Paolo Piccaluga is an Associate Professor of Pathology at the Department of Medical and Surgical Sciences at the Bologna University School of Medicine. He is also a co-founder and Executive Physician at the Biobank of Research, IRCCS S. Orsola-Malpighi Hospital in Italy. He has led the Molecular Hematopathology Laboratory for many years. In 2018, he was appointed to teach at Queen Mary University of London (UK) and Jomo Kenyatta University of Agriculture and Technology in Nairobi (Kenya), and since 2023, at the University of Nairobi and the University of Botswana. He is the author of several international publications indexed in the Current Contents (including Nature Medicine, Journal of Clinical Investigation, Journal of Experimental Medicine, Journal of Clinical Oncology, Blood, Lancet Oncology, and Lancet Infectious Diseases, with a total impact factor >1,000, a mean impact factor >6, and an H-index of 62 (ranked among the VIA-Academy Top Italian Scientists). He is the author of several presentations at national and international conferences. Dr. Piccaluga has participated in several clinical trials as a coordinator or sub-investigator and has won multiple awards for his contributions to study and research. He has served as a Principal Investigator (PI) in various research projects funded by nationally and internationally recognized organizations. He is the Editor-in-Chief of the World Journal of Hematology, Digital Medicine and Healthcare Technology, Advances in Precision Medicine, and the Journal of Cancer Biomoleculars and Therapeutics.
Organizing Committee Chair (In no particular order)
Na He, Dean & Professor for the School of Public Health, Fudan University, China
Xiang Gao, Dean & Professor for the Institute of Nutrition, Fudan University
Organizing Committee Executive Chair (In no particular order)
Ling Tao, Researcher, Fudan University, China
Zefeng Wang, Distinguished Professor, Huzhou University, China
Shuwen Han, Laboratory Director, Tarim University, China
Organizing Committee Member (In no particular order)
Ahmed G. Hegazi, National Research Center, Egypt
Chun Zhou, Zhejiang University, China
Guodong Lu, Fudan University, China
Jinlan Zhang, Peking Union Medical College, Chinese Academy of Medical Sciences, China
Kuan Hu, Peking Union Medical College, Chinese Academy of Medical Sciences, China
Michael Thompson, University of Toronto, Canada
Shouhua Zhang, Jiangxi Provincial children's Hospital, China
Vladan Radosavljevic, Military Medical Academy, Serbia
Xin Wang, China Medical University, China
Yuhan Chen, Seventh Medical Center, Chinese People's Liberation Army General Hospital, China
Zhenlan Du, Seventh Medical Center, Chinese People's Liberation Army General Hospital, China